(Q51560819)

English

Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers.

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10496303

Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10496303

pharmacokinetics

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

F Brown

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10496303

L Banken

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10496303

K Saywell

3

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10496303

I Arum

4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10496303

publication date

1 August 1999

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10496303

Clinical Pharmacokinetics

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10496303

37

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10496303

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10496303

167-176

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10496303

Clinical patterns and treatment of cytomegalovirus infection after solid-organ transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10496303

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

1 reference

https://pubmed.ncbi.nlm.nih.gov/10496303

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10496303

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ganciclovir absolute bioavailability and steady-state pharmacokinetics after oral administration of two 3000-mg/d dosing regimens in human immunodeficiency virus— and cytomegalovirus-seropositive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10496303

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytomegalovirus Infection in Patients with AIDS

1 reference

https://pubmed.ncbi.nlm.nih.gov/10496303

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-dose pharmacokinetics of valganciclovir in HIV- and CMV-seropositive subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/10496303

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of cytomegalovirus retinopathy with ganciclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/10496303

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: a phase I/II study. AIDS Clinical Trials Group, and Cytomegalovirus Cooperative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10496303

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytomegalovirus retinitis and acquired immunodeficiency syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/10496303

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of cytomegalovirus infection in solid-organ transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10496303

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal sustained-release ganciclovir implantation to control cytomegalovirus retinitis in AIDS

1 reference

https://pubmed.ncbi.nlm.nih.gov/10496303

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003088-199937020-00005

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10496303

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10496303

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51560819&oldid=2210902173"